Koch Thomas Von serves as Executive at DiaMedica Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Koch Thomas Von has executed 3 insider transactions totaling $17.1M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 23, 2025 involved purchasing 2,857,142 shares valued at $10.0M.
Koch Thomas Von currently holds 8,383,577 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Koch Thomas Von has been a net buyer of DMAC stock. They have purchased $13.5M and sold $3.5M worth of shares.
Koch Thomas Von's most recent insider trade was on Jul 23, 2025, when they purchased 2,857,142 shares at $3.50 per share.
Get notified when new Form 4 filings are submitted
| $1.24 |
| Discretionary |
| Dec 2, 2022 | DMAC | $3.5M | Purchase | 2,855,847 | $1.24 | Discretionary |